it is concluded that d4975 may be more useful in the treatment of shock than either dopamine or dobutamine because ( a ) it is more potent during shock than dobutamine ( perhaps as a result of phosphodiesterase inhibition by the theophylline component of d4975 ) ;
C0036974
shock
C0013030
dopamine